Sign in
Join
Home
About Us
Privacy Policy
Disclaimer
Advertise On Market Exclusive
Sitemap
Submit a Scoop!
Contact Us
Stock Market News
Stocks
Analyst Ratings
Insider Trading
SEC Filings
Earnings
Cannabis Stocks News
Biotech Stocks
Small Caps
Blockchain & Cryptocurrency
Become a Contributor!
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
My Account
orders
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Market Exclusive
Home
About Us
Privacy Policy
Disclaimer
Advertise On Market Exclusive
Sitemap
Submit a Scoop!
Contact Us
Stock Market News
Stocks
Analyst Ratings
Insider Trading
SEC Filings
Earnings
Cannabis Stocks News
Biotech Stocks
Small Caps
Blockchain & Cryptocurrency
Become a Contributor!
Home
Tags
ACRS
Tag: ACRS
Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Files An 8-K Regulation FD Disclosure
ME Staff 8-k
-
April 4, 2019
0
Aclaris Therapeutics Inc (NASDAQ:ACRS) had its Buy rating reiterated by Cantor...
ME Staff
-
March 22, 2019
0
Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Files An 8-K Results of Operations and...
ME Staff 8-k
-
March 18, 2019
0
Aclaris Therapeutics Inc (NASDAQ:ACRS) had its Buy rating reiterated by Cantor...
ME Staff
-
March 15, 2019
0
Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Files An 8-K Other Events
ME Staff 8-k
-
February 8, 2019
0
Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Files An 8-K Financial Statements and Exhibits
ME Staff 8-k
-
January 18, 2019
0
Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Files An 8-K Entry into a Material...
ME Staff 8-k
-
December 3, 2018
0
Aclaris Therapeutics Inc (NASDAQ:ACRS) price target lowered to $34.00 by JMP...
ME Staff
-
October 16, 2018
0
Aclaris Therapeutics Inc (NASDAQ:ACRS) had its Buy rating reiterated by JMP...
ME Staff
-
October 16, 2018
0
Aclaris Therapeutics Inc (NASDAQ:ACRS) price target set to $50.00 by Cantor...
ME Staff
-
August 3, 2018
0
1
2
3
4
Page 1 of 4
/* */
// AST – IMS - [MarketExclusive_ROS]